Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Statistical Methods in Medical Research|August 27, 2010
Investigating variability in patient response to treatment--a case study from a replicate cross-over studyStephen Senn, Katie Rolfe, Steven A Julious
Parkinson'S Disease|June 21, 2011
Sleep Duration and "on" Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged ReleaseHeinz Reichmann, James Cooper, Katie Rolfe, et al.
Clinical Therapeutics|April 15, 2015
A Retrospective, Pooled Suicidality Evaluation of Ropinirole Immediate Release and Controlled Release for the Treatment of Restless Legs SyndromeClare W Makumi, Walter Paska, Katie Rolfe, et al.
Statistics in Medicine|December 1, 2023
A flexible multi-metric Bayesian framework for decision-making in Phase II multi-arm multi-stage studiesSuzanne M Dufault, Angela M Crook, Katie Rolfe, et al.
Contemporary Clinical Trials|July 11, 2025
Designing a response-over-continuous-intervention (ROCI) randomised trial: Implementation in the Phase 2C part (duration ranging) of the PARADIGM4TB trialTra My Pham, Angela M Crook, Katie Rolfe, et al.
The AAPS Journal|June 6, 2018
Application of the Stable Isotope Label Approach in Clinical Development-Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life CompoundNavin Goyal, Khadeeja Mohamed, Katie Rolfe, et al.
British Journal of Clinical Pharmacology|October 6, 2022
A pharmacometrics approach to assess the feasibility of capillary microsampling to replace venous sampling in clinical studies: Tafenoquine case studySagar S Bachhav, Maxine Taylor, Ana Martin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 14, 2018
Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term SafetyMaria Pia Cicalese, Francesca Ferrua, Laura Castagnaro, et al.
Journal of Clinical Pharmacology|May 15, 2026
Randomized, Placebo-Controlled, First-in-Human Study of the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Oral Doses of Novel Antitubercular Drug Candidate, GSK2556286, in Healthy AdultsEmma Ilsley, Edward Banham-Hall, Tetyana Chaychenko, et al.
Elife|February 7, 2024
Comment on 'The clinical pharmacology of tafenoquine in the radical cure of <i>Plasmodium vivax</i> malaria: An individual patient data meta-analysis'Raman Sharma, Chao Chen, Lionel Tan, et al.
Pageof 2